|Bid||0.0840 x N/A|
|Ask||0.1650 x N/A|
|Day's Range||0.1150 - 0.1150|
|52 Week Range||0.0900 - 1.1500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for THRP.MU
It's shaping up to be a tough period for ThermoGenesis Holdings, Inc. ( NASDAQ:THMO ), which a week ago released some...
ThermoGenesis Holdings, Inc. (THMO) delivered earnings and revenue surprises of -233.33% and 28.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the third quarter ended September 30, 2022 and provided a corporate strategic update.